Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advanced Cell Technology to Participate in Medtech Insight Conference.


WORCESTER, Mass. -- Advanced Cell Technology, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:ACTC ACTC Apple Certified Technical Coordinator
ACTC Almaden Cycle Touring Club
ACTC Associated Colleges of the Twin Cities
ACTC All Ceylon Tamil Congress (Sri Lanka)
ACTC Association Canadienne de Télévision par Câble
) will participate in MedTech Insight's, "Investment in Innovation Conference: A Preview of Early-Stage Medical Technology Companies." The conference will be held on February 23-24, 2006 at The Hyatt Regency Irvine, in Irvine, California Irvine is an incorporated city in Orange County, California, United States. It is a planned city, mainly developed by the Irvine Company since the 1960s. Formally incorporated on December 28 1971, the 69.7 square mile (180.5 km²) city has a population of 202,079 (as of 2007). . Dr. Michael West Michael West may refer to:
  • Dr. Michael Philip West, ESL teacher and researcher
  • Dr. Michael D. West, gerontologist and CEO of BioTime, Inc., former Chairman of the Board and Chief Scientific Officer of Advanced Cell Technology, and former CEO of Geron Corporation
, Chairman of the Board, President and Chief Scientific Officer, is scheduled to present on Friday, February 24th. Additional information regarding the conference can be found at www.medtechinsight.com.

Dr. West's slide presentation will be available on Advanced Cell Technology's website in the Conference Presentations section at www.advancedcell.com/conference-presentations.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 technology in the emerging field of regenerative re·gen·er·a·tive  
adj.
1. Of, relating to, or marked by regeneration.

2. Tending to regenerate.



re·gen
 medicine. The company operates facilities in Alameda, California Alameda is a city in Alameda County, California, United States. It is located on a small island of the same name next to Oakland, California in the San Francisco Bay. An additional part of the city is Bay Farm Island, which is adjacent to the Oakland International Airport.  and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2005.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 23, 2006
Words:365
Previous Article:Accentia Biopharmaceuticals, Inc. to Present at The Wall Street Analyst Forum.
Next Article:Sharp Welcomes Treasury Secretary Snow to Memphis Solar Factory.
Topics:



Related Articles
Nearly 30 Early-Stage Medical Technology Companies Confirmed Thus Far to Present at Medtech Insight's 'Investment In Innovation' Conference in San...
Mir A. Imran to Give Keynote Address at Medtech Insight's San Francisco 'Investment In Innovation: A Preview of Early-Stage Medical Technology...
Attendance Space Filling Up at Medtech Insight's 'Investment In Innovation' Emerging Medical Technology Conference, San Francisco, June 8-9, 2004.
Bioheart, Inc. To Present at Medtech Insight's ``Investment In Innovation'' Conference.
Quantum Dot Corp. to Present at Medtech Insight's ``Investment In Innovation'' Conference.
Gamida-Cell's Early Pre-clinical Studies Indicate Expanded; Population of Stem Cells Successfully Reverses Diabetes.
Medtech Insight and Windhover Information's 'Investment In Innovation' Medical Technology Investment Conference to Feature Interactive Panel...
Hear Presentations from Nearly 40 Early-Stage Cardiovascular, Spine/Orthopedics, Biotechnology and Other Emerging Medical Technology Companies from...
Venture Capital Panel Focuses on Exit Strategies at Medtech Insight and Windhover Information's ``In3 Medical Device Summit'' - The Largest Strategic...
Medtech Insight and Windhover Information's 2006 ``Investment in Innovation (In3) Europe: A Preview of Emerging Medical Technologies'' Premier...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles